EDGAR Filing Documents for 0001493152-17-003536

Form 8-K - Current report:

SEC Accession No. 0001493152-17-003536

Filing Date

2017-04-05

Accepted

2017-04-05 15:59:24

Documents

Period of Report

2017-03-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	33493
2		ex4-1.htm	EX-4.1	120942
3		ex4-2.htm	EX-4.2	138614
4		ex10-1.htm	EX-10.1	341814
5		ex10-2.htm	EX-10.2	655298
6		ex10-3.htm	EX-10.3	183103
	Complete submission text file	0001493152-17-003536.txt		1474376

Mailing Address 201 GROVE RD THOROFARE NJ 08086

Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698

Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 17742526
SIC: 2835 In Vitro & In Vivo Diagnostic Substances